Dr. Naga Chalasani currently serves as David W. Crabb Professor of Medicine at Indiana University School of Medicine and is a practicing hepatologist.   He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020), Associate Dean for Clinical Research (2017-2020) and Vice President for Academic Affairs   (2021-2024) at Indiana University School of Medicine and Indiana University Health.  He received his MBBS in Kakatiya Medical College (1981-1987) and completed his internal medicine residency (1991-1994) and Gastroenterology and Hepatology fellowship (1994-1997) at Emory University in Atlanta, USA.  

His research is focused on nonalcoholic fatty liver disease (NAFLD) and drug induced liver injury (DILI), two highly significant public health problems.  His research has been continuously funded by the National Institutes of Health since 1999.  He is a founding principal investigator of the NIDDK funded NASH CRN and is the PI for the HIV NASH CRN.  He was the lead author for the practice guideline on the Diagnosis and Management of Nonalcoholic Fatty Liver Disease by multiple societies (AASLD, ACG, and AGA) in 2012 which was updated in 2022 by the AASLD. He is the founding PI for the NIDDK funded Drug Induced Liver Injury Network and is the lead author for the ACG Practice Guideline on the Diagnosis and Management of Drug Induced Liver Injury. 

He published over 600 papers including 400 original papers, 3 Practice Guidelines, 52 book chapters/review articles, 35editorials/commentaries, 21 symposium proceedings, and more than 700 abstracts (Google Scholar H-index 118, i10 index 446 with ~ 72,710 citations). He is an elected member of the Alpha Omega Alpha, American Society of Clinical Investigation (ASCI) and the American Association of Physicians (AAP).